"Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease
暂无分享,去创建一个
[1] D. G. Gorman,et al. Creutzfeldt‐Jakob disease in a pathologist , 1992, Neurology.
[2] M. Palmer,et al. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease , 1991, The Lancet.
[3] T. Miyatake,et al. Creutzfeldt‐Jakob disease in a patient with a cadaveric dural graft , 1991, Neurology.
[4] A. Buescu,et al. Pituitary growth hormone and Creutzfeldt-Jakob disease. , 1991, BMJ.
[5] P. Beauvais,et al. Creutzfeldt-Jakob disease in children treated with growth hormone , 1991, The Lancet.
[6] M. Preece,et al. Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. , 1991, BMJ.
[7] D. Wysowski,et al. Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. , 1991, JAMA.
[8] P. Blumbergs,et al. Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin. , 1990, Australian and New Zealand journal of medicine.
[9] G. Macchi,et al. Transmission of Creutzfeldt-Jakob disease by dural cadaveric graft. , 1989, Journal of neurosurgery.
[10] R. Kalb,et al. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report. , 1988, Journal of neurosurgery.
[11] C. Merril,et al. Creutzfeldt‐Jakob disease following pituitary‐derived human growth hormone therapy , 1988, Neurology.
[12] E. Hedley‐Whyte,et al. Preclinical Creutzfeldt‐Jakob disease discovered at autopsy in a human growth hormone recipient , 1988, Neurology.
[13] P. Brown,et al. A new case of Creutzfeldt‐Jakob disease associated with human growth hormone therapy in New Zealand , 1988, Neurology.
[14] E. Hedley‐Whyte,et al. Neuropathologic verification of Creutzfeldt‐Jakob disease in the exhumed American recipient of human pituitary growth hormone , 1986, Neurology.
[15] J. Parisi,et al. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. , 1985, The New England journal of medicine.
[16] B. Berg,et al. Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone. , 1985, The New England journal of medicine.
[17] M. Preece,et al. CREUTZFELDT-JAKOB DISEASE AFTER ADMINISTRATION OF HUMAN GROWTH HORMONE , 1985, The Lancet.
[18] R. Will,et al. Evidence for case-to-case transmission of Creutzfeldt-Jakob disease , 1982, Journal of neurology, neurosurgery, and psychiatry.
[19] C. Masters,et al. Transmissible spongiform encephalopathy (Creutzfeldt-Jakob disease). Atypical clinical and pathological findings. , 1981, Archives of neurology.
[20] D. Gajdusek,et al. DANGER OF ACCIDENTAL PERSON-TO-PERSON TRANSMISSION OF CREUTZFELDT-JAKOB DISEASE BY SURGERY , 1977, The Lancet.
[21] A. Devoe,et al. Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease. , 1974, The New England journal of medicine.
[22] H. Markus,et al. Creutzfeldt-Jakob disease in recipients of human growth hormone in the United Kingdom: a clinical and radiographic study. , 1992, The Quarterly journal of medicine.
[23] G. Macchi,et al. Combination ultrafiltration and 6 M urea treatment of human growth hormone effectively minimizes risk from potential Creutzfeldt-Jakob disease virus contamination. , 1991, Hormone research.
[24] Dc Miller,et al. Creutzfeldt-Jakob disease in histopathology technicians. , 1988, The New England journal of medicine.